Cargando…
Multi-Faceted Influence of Obesity on Type 1 Diabetes in Children – From Disease Pathogenesis to Complications
The prevalence of overweight and obesity among youth patients with diabetes type 1 is increasing. It is estimated, that even up to 35% of young patients with this type of diabetes, considered so far to be characteristic for slim figure, are overweight or even obese. General increase of obesity in ch...
Autores principales: | , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9243381/ https://www.ncbi.nlm.nih.gov/pubmed/35784568 http://dx.doi.org/10.3389/fendo.2022.890833 |
_version_ | 1784738296262295552 |
---|---|
author | Ciężki, Sebastian Kurpiewska, Emilia Bossowski, Artur Głowińska-Olszewska, Barbara |
author_facet | Ciężki, Sebastian Kurpiewska, Emilia Bossowski, Artur Głowińska-Olszewska, Barbara |
author_sort | Ciężki, Sebastian |
collection | PubMed |
description | The prevalence of overweight and obesity among youth patients with diabetes type 1 is increasing. It is estimated, that even up to 35% of young patients with this type of diabetes, considered so far to be characteristic for slim figure, are overweight or even obese. General increase of obesity in children’s population complicates differential diagnosis of the type of diabetes in youths. Coexistence of obesity has clinical implications for all stages of diabetes course. It is confirmed that obesity is the risk factor for autoimmune diabetes, and is connected with the earlier onset of diabetes in predisposed patients. Many diabetic patients with obesity present additional risk factors for macroangiopathy, and are recognised to present metabolic syndrome, insulin resistance, and typical for diabetes type 2 - polycystic ovary syndrome, or non-alcoholic fatty liver disease. The prevalence of obesity rises dramatically in adolescence of diabetic child, more often in girls. It has negative impact on metabolic control, glycaemic variability and insulin demand. The risk for microangiopathic complications increases as well. The treatment is difficult and includes not only insulinotherapy and non-pharmacological trials. Recently treatment of insulin resistance with biguanids, and treatment with typical for type 2 new diabetes drugs like GLP-1 analogues, SGLT-2 receptor inhibitors, or even cases of bariatric surgery also has been reported. |
format | Online Article Text |
id | pubmed-9243381 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | Frontiers Media S.A. |
record_format | MEDLINE/PubMed |
spelling | pubmed-92433812022-07-01 Multi-Faceted Influence of Obesity on Type 1 Diabetes in Children – From Disease Pathogenesis to Complications Ciężki, Sebastian Kurpiewska, Emilia Bossowski, Artur Głowińska-Olszewska, Barbara Front Endocrinol (Lausanne) Endocrinology The prevalence of overweight and obesity among youth patients with diabetes type 1 is increasing. It is estimated, that even up to 35% of young patients with this type of diabetes, considered so far to be characteristic for slim figure, are overweight or even obese. General increase of obesity in children’s population complicates differential diagnosis of the type of diabetes in youths. Coexistence of obesity has clinical implications for all stages of diabetes course. It is confirmed that obesity is the risk factor for autoimmune diabetes, and is connected with the earlier onset of diabetes in predisposed patients. Many diabetic patients with obesity present additional risk factors for macroangiopathy, and are recognised to present metabolic syndrome, insulin resistance, and typical for diabetes type 2 - polycystic ovary syndrome, or non-alcoholic fatty liver disease. The prevalence of obesity rises dramatically in adolescence of diabetic child, more often in girls. It has negative impact on metabolic control, glycaemic variability and insulin demand. The risk for microangiopathic complications increases as well. The treatment is difficult and includes not only insulinotherapy and non-pharmacological trials. Recently treatment of insulin resistance with biguanids, and treatment with typical for type 2 new diabetes drugs like GLP-1 analogues, SGLT-2 receptor inhibitors, or even cases of bariatric surgery also has been reported. Frontiers Media S.A. 2022-06-16 /pmc/articles/PMC9243381/ /pubmed/35784568 http://dx.doi.org/10.3389/fendo.2022.890833 Text en Copyright © 2022 Ciężki, Kurpiewska, Bossowski and Głowińska-Olszewska https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms. |
spellingShingle | Endocrinology Ciężki, Sebastian Kurpiewska, Emilia Bossowski, Artur Głowińska-Olszewska, Barbara Multi-Faceted Influence of Obesity on Type 1 Diabetes in Children – From Disease Pathogenesis to Complications |
title | Multi-Faceted Influence of Obesity on Type 1 Diabetes in Children – From Disease Pathogenesis to Complications |
title_full | Multi-Faceted Influence of Obesity on Type 1 Diabetes in Children – From Disease Pathogenesis to Complications |
title_fullStr | Multi-Faceted Influence of Obesity on Type 1 Diabetes in Children – From Disease Pathogenesis to Complications |
title_full_unstemmed | Multi-Faceted Influence of Obesity on Type 1 Diabetes in Children – From Disease Pathogenesis to Complications |
title_short | Multi-Faceted Influence of Obesity on Type 1 Diabetes in Children – From Disease Pathogenesis to Complications |
title_sort | multi-faceted influence of obesity on type 1 diabetes in children – from disease pathogenesis to complications |
topic | Endocrinology |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9243381/ https://www.ncbi.nlm.nih.gov/pubmed/35784568 http://dx.doi.org/10.3389/fendo.2022.890833 |
work_keys_str_mv | AT ciezkisebastian multifacetedinfluenceofobesityontype1diabetesinchildrenfromdiseasepathogenesistocomplications AT kurpiewskaemilia multifacetedinfluenceofobesityontype1diabetesinchildrenfromdiseasepathogenesistocomplications AT bossowskiartur multifacetedinfluenceofobesityontype1diabetesinchildrenfromdiseasepathogenesistocomplications AT głowinskaolszewskabarbara multifacetedinfluenceofobesityontype1diabetesinchildrenfromdiseasepathogenesistocomplications |